Phase II trial of enzastaurin (Enz) with bevacizumab (BV) in adults with recurrent glioblstoma (GBM).

被引：1
|
作者：
Moustakas, A.
Iwamoto, F. M.
Kreisl, T. N.
Sul, J.
Kim, L. J.
Butman, J. A.
Albert, P. S.
Fine, H. A.
机构：
[1] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA
[2] Univ Massachusetts, Sch Med, Worcester, MA USA
[3] NIH, Bethesda, MD 20892 USA
[4] NCI, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e12511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12511
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PHASE II AND PHARMACOGENOMICS (PGX) STUDY OF ENZASTAURIN (ENZ) PLUS TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) OR GLIOSARCOMA (GS)
    Butowski, Nicholas A.
    Lamborn, Kathleen L.
    Polley, Mei-Yin C.
    Hsieh, Emily
    Kivett, Valerie
    Page, Margaretta S.
    Parvataneni, Rupa
    Nicol, Steve
    Thornton, Don
    Prados, Michael
    NEURO-ONCOLOGY, 2009, 11 (05) : 621 - 621
  • [22] Time to deterioration in dimensions of health-related quality of life (HRQL) for patients with recurrent glioblastoma multiforme (GBM): Results from the randomized, phase III trial of enzastaurin (ENZ) versus lomustine (CCNU)
    van den Bent, M. J.
    Wick, W.
    Liepa, A. M.
    Puduvalli, V. K.
    Carpentier, A. F.
    Cher, L.
    Mason, W. P.
    Taphoorn, M. J.
    Hong, S.
    Fine, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] A phase I trial of gefitinib and sirolimus in adults with recurrent glioblastoma multiforme (GBM)
    Phuphanich, S.
    Rudnick, J.
    Chu, R.
    Yu, J. S.
    Black, K. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] A phase II trial of lithium, bevacizumab, temozolomide, and radiation for newly diagnosed glioblastomas (GBM).
    Narayana, Ashwatha
    Tam, Moses M.
    Gruber, Deborah Beth
    Golfinos, John
    Parker, Erik
    Zagzag, David
    Gruber, Michael L.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma
    Puduvalli, Vinay K.
    Wu, Jing
    Yuan, Ying
    Armstrong, Terri S.
    Vera, Elizabeth
    Wu, Jimin
    Xu, Jihong
    Giglio, Pierre
    Colman, Howard
    Walbert, Tobias
    Raizer, Jeffrey
    Groves, Morris D.
    Tran, David
    Iwamoto, Fabio
    Avgeropoulos, Nicholas
    Paleologos, Nina
    Fink, Karen
    Peereboom, David
    Chamberlain, Marc
    Merrell, Ryan
    Prado, Marta Penas
    Yung, W. K. Alfred
    Gilbert, Mark R.
    NEURO-ONCOLOGY, 2020, 22 (10) : 1505 - 1515
  • [26] A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS
    Puduvalli, Vinay
    Wu, Jing
    Yuan, Ying
    Armstrong, Terri
    Wu, Jimin
    Giglio, Pierre
    Xu, Jihong
    Colman, Howard
    Walbert, Tobias
    Raizer, Jeffrey
    Groves, Morris
    Iwamoto, Fabio
    Tran, David
    Avgeropoulos, Nicholas
    Paleologos, Nina
    Fink, Karen
    Peereboom, David
    Chamberlain, Marc
    Merrell, Ryan
    Penas-Prado, Marta
    Yung, W. K. Alfred
    Gilbert, Mark
    NEURO-ONCOLOGY, 2018, 20 : 13 - 13
  • [27] A phase II trial of lapatinib and pazopanib for patients with recurrent glioblastoma multiforme (GBM)
    Reardon, David
    Groves, Morris
    Wen, Patrick
    Nabors, Louis
    Mikkelsen, Tom
    Rosenfeld, Steve
    Harris, Dean
    DeMarini, Douglas
    Suttle, Ben
    Arumugham, Thangam
    Hodge, Jeffrey
    Lager, Joanne
    NEURO-ONCOLOGY, 2007, 9 (04) : 516 - 516
  • [28] Phase II trial of erlotinib plus sirolimus for recurrent glioblastoma multiforme (GBM)
    Friedman, H. S.
    Desjardins, A.
    Vredenburgh, J. J.
    Rich, J. N.
    Sathornsumetee, S.
    Gururangan, S.
    Quinn, J. A.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    McLendon, Roger E.
    Marcello, Jennifer
    Herndon, James E.
    Mathe, Alyssa
    Hamilton, Marta
    Rich, Jeremy N.
    Norfleet, Julie A.
    Gururangan, Sridharan
    Friedman, Henry S.
    Reardon, David A.
    NEURO-ONCOLOGY, 2010, 12 (12) : 1300 - 1310
  • [30] FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM
    Brandes, Alba A.
    Finocchiaro, Gaetano
    Zagonel, Vittorina
    Reni, Michele
    Fabi, Alessandra
    Caserta, Claudia
    Clavarezza, Matteo
    Maiello, Evaristo
    Carteni, Giacomo
    Rosti, Giovanni
    Eoli, Marica
    Lombardi, Giuseppe
    Monteforte, Marta
    Agati, Raffaele
    Eusebi, Vincenzo
    Galli, Anna
    Doria, Simona
    Franceschi, Enrico
    NEURO-ONCOLOGY, 2014, 16
12345